Department of Family Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 2, Minsheng Road, Dalin, 622, Chiayi, Taiwan.
Department of Nephrology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), 670 Chung-Te Road, Tainan, 701, Taiwan.
BMC Nephrol. 2019 Jul 16;20(1):265. doi: 10.1186/s12882-019-1440-9.
Palliative care has improved the quality of end-of-life (EOL) care and lowered the health care cost of cancer, and these benefits should be extended to patients with other serious illnesses including end-stage kidney disease. We evaluated the quality of EOL care, survival probabilities, and health care costs for dialysis patients in their last month of life.
We conducted a population-based study and analyzed data from Taiwan's Longitudinal Health Insurance Database, which contains claims information of patient medical records, health care costs, and insurance system exit dates (our proxy for death between 2006 and 2011).
Data of 1177 adult patients who died of chronic hemodialysis or peritoneal dialysis were investigated. The mean age of these patients was 69.7 ± 11.9 years, and 585 (49.7%) were women. Some patients with dialysis received cardiopulmonary resuscitation (66.9%), died in a hospital (65.0%), or were admitted to an intensive care unit (51.0%) in the last month of life. We further classified these patients into two groups, namely dialysis with cancer (DC) (n = 149) and dialysis without cancer (D) (n = 1028). Only 19 dialysis patients received palliative care, and the proportion of patients receiving palliative care was higher in the DC group than in the D group (11.4% vs. 0.2%). The mean health care costs per person during the final month of life was similar between the DC and D groups (USD 2755 ± 259 vs. USD 2827 ± 88). Multivariate logistic regression showed that the DC group had lower odds of receiving cardiopulmonary resuscitation (CPR) (OR: 0.39, CI = 0.26-0.56, p < 0.001) procedures, higher odds of longer hospital stays than the third quartile (> 25 days) (OR: 1.52, CI = 1.01-2.29, p = 0.0046), and higher odds of being hospitalized more than once (OR: 2.26, CI = 1.42-3.59, p = 0.001) than the D group in the last month of life after adjustments.
DC patients received hospice care more frequently, received CPR less frequently, and had similar health care costs. DC patients also had a higher risk of a hospital stay that lasted more than 25 days and more than one hospitalization compared with D patients in the final month of life.
姑息治疗改善了终末期疾病(EOL)患者的生活质量并降低了癌症的医疗保健费用,这些益处应该扩展到患有其他严重疾病(包括终末期肾病)的患者。我们评估了终末期透析患者的 EOL 护理质量、生存概率和医疗保健费用。
我们进行了一项基于人群的研究,并分析了来自台湾长期健康保险数据库的数据,该数据库包含了患者病历的索赔信息、医疗保健费用和保险系统退出日期(我们在 2006 年至 2011 年之间将其作为死亡的代理)。
调查了 1177 名死于慢性血液透析或腹膜透析的成年患者的数据。这些患者的平均年龄为 69.7±11.9 岁,其中 585 名(49.7%)为女性。一些接受透析治疗的患者在最后一个月接受心肺复苏术(66.9%)、在医院死亡(65.0%)或入住重症监护病房(51.0%)。我们进一步将这些患者分为两组,即伴有癌症的透析组(DC)(n=149)和不伴有癌症的透析组(D)(n=1028)。只有 19 名透析患者接受了姑息治疗,且 DC 组接受姑息治疗的患者比例高于 D 组(11.4% vs. 0.2%)。在最后一个月的生命中,每个人的平均医疗保健费用在 DC 和 D 组之间相似(2755 美元±259 美元 vs. 2827 美元±88 美元)。多变量逻辑回归显示,DC 组接受心肺复苏术(CPR)的可能性较低(OR:0.39,CI=0.26-0.56,p<0.001),接受 CPR 的可能性低于第三四分位数(>25 天)的可能性更高(OR:1.52,CI=0.99-2.37,p=0.0577),且在调整后的最后一个月住院时间超过 25 天(OR:1.32,CI=1.00-1.76,p=0.0488)和住院一次以上的可能性更高(OR:2.26,CI=1.42-3.59,p=0.001)。
DC 患者更频繁地接受临终关怀护理,较少接受 CPR,并且医疗保健费用相似。与 D 组相比,DC 组在最后一个月的生命中,住院时间超过 25 天和住院超过一次的风险更高。